-
ERFINDERGEMEINSCHAFT UROPEP GbR v. Eli Lilly and Company et al DC CAFC
- 2:15-cv-01202
- E.D. Tex.
- Judge: William C. Bryson
- Filed: 07/01/2015
- Closed: 08/25/2017
- Latest Docket Entry: 02/28/2019
- PACER
- Docket updated daily
1
Plaintiff
2
Defendants
1
Accused
Product
1
Patent-in-Suit
787
Days in
Litigation
-
ERFINDERGEMEINSCHAFT UROPEP GbR v. Eli Lilly and Company et al DC CAFC
- 2:15-cv-01202
- E.D. Tex.
- Judge: William C. Bryson
- Filed: 07/01/2015
- Closed: 08/25/2017
- Latest Docket Entry: 02/28/2019
- PACER
- Docket updated daily
Market Sector
Biotech and Pharma
Assigned Judge
Outcome Summary
- Patent Information
-
Validity & Enforceability
Claim # | Claim Text | Outcome |
---|---|---|
1 |
A method for prophylaxis or treatment of benign prostatic hyperplasia comprising administering to a person in need thereof an effective amount of an inhibitor of phosphodiesterase (PDE) V excluding a compound selected from the group consisting of
view more
|
Valid (102 and 103 and 112)
Entry 335 |
-
Infringement
Eli Lilly and Company
- 1 Detail
Accused Product | Patent # | Claim # | Outcome |
---|---|---|---|
Cialis | US 8,791,124 B2 | All Asserted Claims |
Infringement
Entry 387Entry 360 Entry 335 |
-
Damages
Total Damages:
$20,000,000.00Other Costs:
$1,030,585.08Dockets:
- Compensatory Damages: $20,000,000.00
- Court Costs: $100,485.08
- Pre Judgment Interest: $930,100.00